FOXM1 and breast cancer: We further compared the OS and DSS of HR+HER2- BC patients between high KPNA2 and low FOXM1 expressions with the other groups; the high KPNA2 and low FOXM1 BC patients had significantly better OS and DSS rates (Figure 5b, second row).